Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

meaning Nevro’s full-year guidance for 2025 dropped from $435-445m to $400m-$405m. Boston Scientific’s Wavewriter spinal cord stimulator systems, for example, gained access to a wider market ...

Nevro Corp. engages in the development of medical ... It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of ...

The market includes spinal cord stimulation (SCS) systems as well as peripheral nerve stimulation (PNS) systems - ...